Company Quick10K Filing
Insperity
10-Q 2021-03-31 Filed 2021-05-04
10-K 2020-12-31 Filed 2021-02-12
10-Q 2020-09-30 Filed 2020-11-02
10-Q 2020-06-30 Filed 2020-08-04
10-Q 2020-03-31 Filed 2020-05-05
10-K 2019-12-31 Filed 2020-02-12
10-Q 2019-09-30 Filed 2019-11-04
10-Q 2019-06-30 Filed 2019-07-29
10-Q 2019-03-31 Filed 2019-04-29
10-K 2018-12-31 Filed 2019-02-11
10-Q 2018-09-30 Filed 2018-11-01
10-Q 2018-06-30 Filed 2018-08-01
10-Q 2018-03-31 Filed 2018-04-30
10-K 2017-12-31 Filed 2018-02-12
10-Q 2017-09-30 Filed 2017-11-01
10-Q 2017-06-30 Filed 2017-08-01
10-Q 2017-03-31 Filed 2017-05-01
10-K 2016-12-31 Filed 2017-02-13
10-Q 2016-09-30 Filed 2016-11-01
10-Q 2016-06-30 Filed 2016-08-01
10-Q 2016-03-31 Filed 2016-05-02
10-K 2015-12-31 Filed 2016-02-12
10-Q 2015-09-30 Filed 2015-11-02
10-Q 2015-06-30 Filed 2015-08-03
10-Q 2015-03-31 Filed 2015-05-01
10-K 2014-12-31 Filed 2015-02-10
10-Q 2014-09-30 Filed 2014-11-03
10-Q 2014-06-30 Filed 2014-08-01
10-Q 2014-03-31 Filed 2014-05-02
10-K 2013-12-31 Filed 2014-02-10
10-Q 2013-09-30 Filed 2013-11-01
10-Q 2013-06-30 Filed 2013-08-01
10-Q 2013-03-31 Filed 2013-04-29
10-K 2012-12-31 Filed 2013-02-11
10-Q 2012-09-30 Filed 2012-11-01
10-Q 2012-06-30 Filed 2012-07-31
10-Q 2012-03-31 Filed 2012-04-30
10-K 2011-12-31 Filed 2012-02-14
10-Q 2011-09-30 Filed 2011-11-01
10-Q 2011-06-30 Filed 2011-08-01
10-Q 2011-03-31 Filed 2011-05-02
10-K 2010-12-31 Filed 2011-02-14
10-Q 2010-09-30 Filed 2010-11-01
10-Q 2010-06-30 Filed 2010-08-02
10-Q 2010-03-31 Filed 2010-05-03
10-K 2009-12-31 Filed 2010-02-11
8-K 2020-11-02
8-K 2020-08-03
8-K 2020-05-22
8-K 2020-05-04
8-K 2020-04-08
8-K 2020-02-11
8-K 2020-01-03
8-K 2019-12-02
8-K 2019-11-04
8-K 2019-09-16
8-K 2019-07-29
8-K 2019-05-28
8-K 2019-04-29
8-K 2019-02-11
8-K 2018-05-29
8-K 2018-05-07
8-K 2018-04-30
8-K 2018-02-12
8-K 2018-01-08

Insperity Financials

NSP Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash169208235278265170211235181202265227178162226214169179276229168201270319272224286304242286354396516523535615556459
Accounts Receivable111122843272327334124338243135331244310
Inventory
PP&E227228230235240247252255259260262265267268268269273275281246249251252259265272283293300304310316323101351116121135
Assets6086266607296846367127426827307507617087107677997377797978417537807858818467959079298869471,0641,0911,0511,1371,1921,3511,3171,292
Accounts Payable123323533342333323532355444533664511875
Long-Term Debt104104104104104104104104104104104144144169239
Liabilities3783944194804323984674854304705095214674625135524905315936285626046128257827258478428028459979899339851,1141,2321,1821,251
Stockholders' Equity230232240248251238245256253260241239241249253247247248204213191176172556570618684102661031181527811913541
Income Statement ($MM)2010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue4124144365364734724955955195125326126475405576375655605966996286266508027077037298837967968261,0149229259671,1531,0431,043
Cost of Revenue341340355445389385405492432414439504549442467531460459495570524520553652594585619723665656684815768759805926870873
Gross Profit7174819184879010387989410898979010610410110113010410797150113118111159131140143200155166162227174171
R&D
SG&A15161622171918221821162220211923232018242019212421212026252526302725333030
Tax4557536948794727265105842068518911915101311119
Net Income5789741114611913310510288147126331014103614191650253625762926
Cash Flow ($MM)2010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating583159-5-416133-36286617-39-13699-3828143-38-34469195-35-269844-315713424-653118-45-25
Cash Investing-12-3-14-1-35-12-5-6128-38-62-2-3-1-79-3320-83-8-9-13-12-9-6-7-7-13-382-19-18
Cash Financing-8-1-3-6-19-8-5-12-7-31-17-5-6-3-18-5-10-55-7-31-32-14-49-5-14-23-14-22-8-59-17-157240-6-123